INPP4B is regarded as a tumour suppressor of LC because it regulates the level of 3-phosphorylated phosphoinositide at the cellular level and activates phosphoinositide in PTEN-deficient cells (Vo & Fruman, 2015). The gene discussed is INPP4B; the disease is laryngotracheoesophageal cleft.